However, as survival probabilities are equally poor for TMM positive and MYCN type and clearly separated from TMM negative, our study shows that DNA methylation-based classification can be used for diagnosing and subclassifying neuroblastoma into clinically relevant groups. Here, MYCN is linked to neuroblastoma.